Cell implant aims to save sight in glaucoma patients
NCT ID NCT04577300
First seen Nov 05, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tests a new treatment for glaucoma, a disease that damages the optic nerve and can lead to blindness. Researchers implant tiny capsules that release a protein to protect nerve cells. Thirty adults with moderate to advanced glaucoma will receive either the implant or a sham procedure. The goal is to see if the implant can slow vision loss over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Byers Eye Institute at Stanford University
Palo Alto, California, 94303, United States
Conditions
Explore the condition pages connected to this study.